financetom
Business
financetom
/
Business
/
Mercedes to step up cost cuts after earnings halve
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mercedes to step up cost cuts after earnings halve
Nov 3, 2024 11:24 AM

(Reuters) - Mercedes-Benz will step up cost cuts after earnings halved in the third quarter hit by tepid demand and fierce competition in China, it said on Friday.

The luxury carmaker cut its full-year profit margin target twice during the third quarter, joining a growing number of European rivals blaming a weakening Chinese car market for falling profits and margins.

It hopes a massive new model rollout will help to revive sales next year.

Mercedes shares fell 1.4% by 0910 GMT, dragging down peers BMW and Volkswagen.

The company stock has lost around 8% year to date, underperforming Germany's benchmark DAX index but still faring better than Volkswagen, BMW, and Porsche AG.

The pan-European autos index is down 10% year-to-date, the worst-performing sector in Europe this year.

PROFITABILITY DROPS

Mercedes's key car division's adjusted return on sales fell to 4.7% in the third quarter from 12.4% last year, its worst profitability since the pandemic, while earnings in the unit more than halved, worse than expected by analysts.

"The Q3 results do not meet our ambitions," CFO Harald Wilhelm said in a statement, adding that the group will step up cost cuts.

Wilhelm declined to provide more details about the cost cuts, but warned that "it will be tighter and tougher for sure".

Europe's biggest automaker, Volkswagen is considering plant closures in Germany for the first time.

The July-September earnings were hit as Chinese consumers continued to cut back on luxury goods in a weakening economy, which has in particular weighed on Mercedes's lucrative high-end S-Class model sales in the country.

Model revamp costs added to the pressure, especially for new versions of the G-Class SUV, which will hit the market in the next quarter, Mercedes added.

In 2024, the company sees car sales slightly below the previous year, and fourth-quarter sales in line with the third quarter.

Nevertheless, Mercedes refuses to reduce prices and prefers to stick to its "value over volume" strategy, including in China.

CHINA WOES

Mercedes-Benz CEO Ola Kaellenius has warned that Chinese consumers are extremely cautious about making big purchases, as long-standing economic weakness and a real estate crisis have created considerable uncertainty for consumers.

Talks between Brussels and Beijing continue over looming tariffs on imports of Chinese EVs into Europe, a major headache for Europe's China-dependent car heavyweights due to the fears of potential retaliation.

Mercedes-Benz, which counts China's Beijing Automotive Group Co Ltd and Geely Chair Li Shufu as its two top shareholders, has called the tariffs a "mistake", urging the European Commission to delay their implementation to allow further talks on a deal.

($1 = 0.9240 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Freight forwarder Kuehne+Nagel to open new site at Texas-Mexico border
Freight forwarder Kuehne+Nagel to open new site at Texas-Mexico border
Mar 18, 2025
By Anastasiia Kozlova (Reuters) - Swiss logistics group Kuehne und Nagel said on Tuesday it would open a new road logistics facility in Texas, close to the Mexican border, to meet growing demand for customs support between the United States and Mexico. Earlier in March, U.S. President Trump imposed 25% tariffs on all imports from Mexico and Canada, then offered...
Telix Pharmaceuticals' Illuccix Approved in Brazil for Prostate Cancer Imaging; Forms Joint Venture With R2PHARMA
Telix Pharmaceuticals' Illuccix Approved in Brazil for Prostate Cancer Imaging; Forms Joint Venture With R2PHARMA
Mar 18, 2025
07:46 AM EDT, 03/18/2025 (MT Newswires) -- Telix Pharmaceuticals ( TLX ) said late Monday that the Brazilian Health Regulatory Agency has approved the company's prostate cancer imaging agent, Illuccix. The company said the approval was granted to Telix's partner, R2PHARMA, and a subsidiary of Grupo GSH, which has been given an exclusive license to manufacture, distribute and market Illuccix...
Google agrees to buy cybersecurity startup Wiz for $32 billion, FT reports
Google agrees to buy cybersecurity startup Wiz for $32 billion, FT reports
Mar 18, 2025
(Reuters) -Google-parent Alphabet has agreed to buy cybersecurity startup Wiz for at least $32 billion, the Financial Times reported on Tuesday, citing people familiar with the matter. This would bolster Google's cloud business with Wiz's AI-powered cybersecurity solutions that companies use to tackle critical risks, helping it better compete with cloud leader Amazon and Microsoft. The deal would be Alphabet's...
BRIEF-Google Parent Alphabet Agrees To Buy Cyber Security Group Wiz For $32 Billion - FT
BRIEF-Google Parent Alphabet Agrees To Buy Cyber Security Group Wiz For $32 Billion - FT
Mar 18, 2025
March 18 (Reuters) - * GOOGLE PARENT ALPHABET AGREES TO BUY CYBER SECURITY GROUP WIZ FOR $32 BILLION - FT * ALPHABET-WIZ DEAL WILL BE ANNOUNCED ON TUESDAY MORNING - FT Source text: https://tinyurl.com/3sfyfwz2 Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved